Evidence map›Paper›PMID 35001970›Full record

ArticleJournal of molecular structure2022

Investigation of Cu metal nanoparticles with different morphologies to inhibit SARS-CoV-2 main protease and spike glycoprotein using Molecular Docking and Dynamics Simulation.

Mohammadreza Aallaei, Elaheh Molaakbari, Paridokht Mostafavi, Navvabeh Salarizadeh, Rahime Eshaghi Maleksah, Dariush Afzali

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular structure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. InBiochemistry and biophysics reports · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Mohammadreza AallaeiDepartment of Chemistry, Faculty of Science, Imam Hossein University, Tehran, Iran.
Elaheh MolaakbariDepartment of Chemistry, Shahid Bahonar University of Kerman, Kerman, Iran.
Paridokht MostafaviDepartment of Environment, Graduate University of Advanced Technology, Kerman, Iran.
Navvabeh SalarizadehDepartment of Cell & Molecular Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
Rahime Eshaghi MaleksahMedical Biomaterial Research Centre (MBRC), Tehran University of Medical Sciences, Tehran, Iran.
Dariush AfzaliDepartment of Environment, Graduate University of Advanced Technology, Kerman, Iran.
Graduate University of Advanced Technology · IRImam Hossein University · IRShahid Bahonar University of Kerman · IRTehran University of Medical Sciences · IRUniversity of Tehran · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nowadays, considering the spread of the coronavirus as a global threat, scientific research on this virus through simulation has been increasing. In this study, effect of Cu nanocluster on prevention and control of disease transmission was examined using molecular docking and molecular dynamics simulation studies on the SARS-CoV-2 main protease and spike glycoprotein. The cytotoxicity of different shapes of copper NPs and resonance changes of their surface plasmons on inactivation of the coronavirus was examined in order to control replication of coronavirus through copper NPs, active site of protease and spike glycoprotein. The simulations results showed that interactions of SARS-CoV-2 main protease and spike glycoprotein target and cylindrical and conical copper NPs ligands were more efficient than spherical copper NPs.

Indexed as

Copper NPsCOVID-19Molecular DockingMolecular Dynamics SimulationProtease and Spike Glycoprotein Inhibitor

Identifiers

PMID35001970
PMCPMC8719269
OpenAlexW4206481943

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.